Replies to post #9033 on Mast Therapeutics, Inc. (MSTX)

[Ecomike]

They will not buy back shares. They will need all that cash for the other two drug trials, etc. IIRC ANX-514 needs a LOT of cash for an expensive phase III next, which we had previously been led to believe might be side stepped or avoided, but IIRC FDA asked for it anyway.